AlphaGen
Access AlphaGen
Company Explained

Fateh Sports Wear at a Standstill: Frozen Receivables, Idle Assets and the Restart Question

Fateh Sports Wear has no current sales. Its economics depend on a restrained US$2 million receivable, director funding, idle assets and an uncertain restart.

Aug 28, 2026

Company in 30 seconds

Company Name: Fateh Sports Wear Ltd

Ticker: FSWL

Fateh Sports Wear was incorporated to manufacture ready-made garments for local sale and export, but it is not currently an operating apparel producer. Manufacturing stopped in March 2015, the company had no employees and no sales in FY2025, and the latest nine-month period through March 2026 again recorded zero sales. Reported earnings now come mainly from changes in the rupee value of a court-restrained US$2 million export receivable, while administration costs and director-funded liquidity consume cash. FY2025 annual report.

The central question is not whether garment margins are improving. It is whether the legal restriction is removed, how much cash becomes accessible, and whether idle facilities, customer relationships and working capital can be rebuilt into a viable business. Until then, profit can move sharply without revenue or operating cash generation. March 2026 interim report.

What matters most

  • Release of restrained funds: the company says US$2 million remains blocked under a Sindh High Court order connected with a family dispute. This receivable represents almost the entire asset base. FY2025 receivable note.
  • Restart credibility: management says production can resume after funds are released and that it has developed an export-marketing strategy. No disclosed order book, capacity plan, working-capital budget or restart timetable yet turns that intention into a forecast. July 2026 progress report.
  • Foreign-exchange translation: the dollar receivable creates gains when the rupee weakens and losses when it strengthens. These entries dominate profit but do not create cash while the money remains restrained. FY2025 result.
  • Asset recoverability: the auditor qualified its FY2025 opinion because the company had not established whether idle property, plant and equipment and suspended capital work in progress required impairment. FY2025 auditor’s report.
  • Liquidity: cash was only Rs118,155 at March 31, 2026, while director loans had risen to Rs33.11 million. Survival depends on related-party funding rather than customer receipts. March 2026 balance sheet.

Key facts and figures

  • Incorporated on May 20, 1984; its registered office and factory are at 442 Mirpurkhas Road, Hyderabad. corporate information.
  • Manufacturing was suspended from 2003, briefly recommenced in 2013 and closed again in March 2015 because scarce finance made operations unviable. operating history.
  • FY2025 sales and gross profit were zero; administration expense was Rs3.03 million. official FY2025 result.
  • FY2025 profit after tax was Rs7.03 million, or Rs3.51 per share, mainly because a Rs10.60 million exchange gain outweighed recurring charges. official FY2025 result.
  • For the nine months ended March 31, 2026, sales remained zero and loss reached Rs12.25 million, or Rs6.12 per share. official March 2026 report.
  • At March 31, 2026, trade receivables were Rs558.10 million—approximately 93% of total assets of Rs600.16 million. March 2026 financial position.
  • At June 30, 2025, the court-restrained foreign receivable was Rs567.20 million, representing US$2 million at the reporting exchange rate. FY2025 receivable note.
  • FY2025 property, plant and equipment was Rs10.10 million and capital work in progress Rs29.84 million; both were covered by the audit qualification. FY2025 audit opinion.
  • FY2025 operating cash flow was negative Rs3.46 million, nearly matched by Rs3.47 million of additional short-term loans. FY2025 cash flow.
  • At March 2026, director loans were Rs33.11 million versus Rs30.28 million at June 2025; cash was only Rs0.12 million. March 2026 accounts.
  • FY2025 equity was Rs573.63 million, but its quality depends heavily on the aged receivable and carrying values of idle assets. FY2025 financial position.
  • The FY2025 report recorded no employees and no dividend. FY2025 directors’ report.
  • PSX currently labels FSWL non-compliant and reports two million shares with a free float of 96,072 shares, or 4.8%. PSX company record.

From garment manufacturer to dormant company

Historical operating model

FSWL’s stated purpose is to manufacture ready-made garments for local and export customers. A functioning apparel operation depends on orders, fabric and trim procurement, labor productivity, quality acceptance, shipment timing and financing the interval between purchasing inputs and collecting export proceeds.

That framework is historical, not current. The company disclosed no production since 2015, no inventory, no sales and no employees in FY2025. It therefore has no current product mix, customer concentration, capacity utilization, export-market split or gross margin that can be analyzed responsibly. FY2025 operating data.

Present-day economics

Today, FSWL pays unavoidable listing, governance, utility, depreciation and administrative costs; directors lend money to meet those costs; and the rupee carrying value of the dollar receivable changes with exchange rates. This can produce large profits or losses despite zero sales.

In FY2025, the exchange gain converted an operating loss into reported profit. During the first nine months of FY2026, a Rs9.10 million exchange loss compounded administration costs and produced a Rs12.25 million loss. Neither period demonstrates demand, pricing power or manufacturing efficiency. March 2026 profit statement.

The frozen receivable

The receivable traces to export claims affected by the breakup of the Soviet Union and the Russian banking settlement process. The annual report says US$3.2 million was placed at the company’s disposal; US$1.2 million, including sea-freight compensation, was received earlier. The remaining US$2 million was restrained after a family member of directors claimed a 33% share. FY2025 legal notes.

Management carries the amount as recoverable and has not recorded an expected-credit-loss provision against it. The Foreign Exchange Adjudication Office vacated related FER cases in September 2023, but payment still depends on settlement of the family cases. Progress in the foreign-exchange proceedings did not make the money available. FY2025 going-concern disclosure.

Accounting gains are not cash

Because the receivable is dollar-linked, exchange-rate changes remeasure its rupee value. A gain increases profit and equity on paper; a loss reverses part of that uplift. AlphaGen’s inference is that FSWL should be read as a legal-recovery and restart situation, not on EPS as though earnings came from garment sales.

Balance-sheet quality

Receivable concentration

At first glance, equity of Rs561.39 million against liabilities of Rs38.77 million at March 2026 appears conservative. Yet Rs558.10 million of trade receivables represented about 93% of assets, and virtually all receivables were more than five years old at June 2025. Reported solvency rests on one concentrated legal asset rather than diversified cash-generating assets. FY2025 credit-risk disclosure.

Idle assets and audit qualification

The auditor could not obtain sufficient evidence on possible impairment of Rs10.10 million of property, plant and equipment after a decade-long shutdown. It raised the same concern over Rs29.84 million of capital work in progress on a suspended renovation project intended partly for rental as a banquet facility. FY2025 qualified audit opinion.

Stores and spares of Rs10.78 million and raw and packing materials of Rs21.41 million were fully provided for as obsolete. A restart may therefore require fresh inputs and refurbishment, not merely switching existing machinery back on. FY2025 inventory notes.

Margins, cash conversion and leverage

There are no current gross, operating or net margins to interpret because sales are zero. The relevant measure is annual cash burn. FY2025 profit of Rs7.03 million coexisted with negative operating cash flow of Rs3.46 million; additional loans of Rs3.47 million kept closing cash near Rs82,931. FY2025 cash-flow statement.

During the nine months to March 2026, directors advanced a further Rs2.83 million. Cash rose to Rs118,155 only because funding narrowly exceeded cash usage and exchange-related movements. Debt is modest versus book equity, but book equity is not spendable liquidity. March 2026 cash-flow statement.

Reading the financial history

Zero sales, volatile profit

Sales were zero in every year from FY2019 through FY2025. Profit before tax nevertheless ranged from a Rs23.95 million loss in FY2021 to profits of Rs93.84 million in FY2022 and Rs158.20 million in FY2023, then a Rs19.90 million loss in FY2024 and Rs7.03 million profit in FY2025. seven-year operating history.

These are not apparel-demand cycles. They mainly reflect foreign-exchange changes on the restrained receivable plus recurring costs. Revenue growth, gross margin, asset turnover and earnings multiples are not economically meaningful while the company remains dormant.

The latest cumulative loss reached Rs12.25 million by March 2026 versus Rs2.43 million a year earlier. The change was largely exchange-driven rather than a deterioration in sales, but it still reduced equity and increased dependence on directors. March 2026 comparatives.

What a credible restart requires

Management’s July 2026 progress report said it was pursuing release of the US$2 million, had developed an international marketing strategy and had contacted buyers. It expected production to restart once the stay order was removed and working capital became available. These are management statements, not confirmed orders or a funded plan. official July 2026 progress report.

  • A legal event making cash unconditionally available, with the amount and settlement terms disclosed.
  • A board-approved use-of-funds plan separating creditor settlement, plant rehabilitation, working capital and liquidity reserves.
  • An independent assessment of machinery, buildings and the suspended project, including impairment and restart capital expenditure.
  • Executable orders showing customer geography, product categories, quantities, delivery schedules and payment terms.
  • Fresh disclosures on capacity, workforce, procurement, energy, quality systems and expected margins.

Until these appear, FSWL has no demonstrated competitive position. Its export history and physical site may be options, but inactivity can weaken equipment, skills, buyer relationships and compliance readiness.

Ownership, governance and market structure

Directors, the chief executive and their families held 82.91% of shares at June 2025. Concentration may support patient sponsor funding, but it also makes the family dispute around the receivable material to minority holders. The annual report said independent directors would be appointed after business activities were restored. FY2025 ownership and governance.

PSX labels FSWL non-compliant and reports only 4.8% free float. This status and small tradable base are market-structure facts, not evidence of recovery. Price movements should not be treated as confirmation that legal funds, orders or production have improved. current PSX profile.

Structural strengths—and their limits

  • The claim is partly realized: FSWL previously received US$1.2 million from the US$3.2 million placed at its disposal. The remaining cash is restrained by a separate dispute, so timing is unresolved. FY2025 legal history.
  • Reported equity is positive and director support has covered operating deficits. This creates time to pursue the case but does not replace external cash generation. March 2026 accounts.
  • The company retains industrial property and a listed corporate vehicle with an export-manufacturing mandate. Their condition, economic value and funding needs remain uncertain. FY2025 asset disclosures.
  • Regular financial and progress reporting provides checkpoints, but disclosures still need to advance from intentions to measurable milestones. company reporting archive.

How to read this company’s results

  • Start with sales, not EPS. A genuine operating recovery must first produce revenue.
  • Reconcile the dollar receivable: amount, rupee value, court status, claimant exposure, cash received and any credit-loss provision.
  • Separate exchange gains or losses from administration costs to reveal underlying cash burn.
  • Watch operating cash flow and director loans together; rising related-party funding shows ongoing liquidity needs.
  • Review impairment disclosures and the audit opinion on idle plant and capital work in progress.
  • After any restart announcement, demand evidence on orders, production, headcount, inventory, utilization, margin and collections.
  • Track PSX compliance and board independence as part of operational normalization.

Principal risks

  • Legal risk: funds may remain inaccessible or settlement may reduce cash available to FSWL.
  • Concentration risk: one aged receivable accounts for almost the entire balance sheet.
  • Impairment risk: idle machinery and suspended work may be worth less or require substantial refurbishment.
  • Restart risk: no firm orders, costed plan or proof of competitive production has been disclosed.
  • Liquidity risk: cash is negligible and recurring expenses rely on director funding.
  • Governance and listing risk: non-compliant status, limited independence and concentrated ownership need monitoring.
  • Reporting risk: the qualified audit opinion limits confidence in parts of the asset base. FY2025 auditor’s report.

What to monitor

  • Any Sindh High Court order or settlement changing control over the US$2 million.
  • Actual cash receipt, not only revaluation of the dollar balance.
  • A funded restart plan with capital expenditure, working-capital needs and timetable.
  • Confirmed orders and the first reported sales after the 2015 shutdown.
  • Director loans, operating cash burn and cash balances.
  • Impairment testing for idle plant and the suspended project.
  • Independent-director appointments and movement out of PSX’s non-compliant classification.
  • Quarterly progress reports containing measurable milestones.

Sources

Explore more research

All articles